Skip to main content
Clinical Trials/PACTR202008475715326
PACTR202008475715326
Completed
未知

EFFECTS OF ANTENATAL ANTIHELMINTHIC TREATMENT ON PREGNANCY OUTCOMES IN UITH ILORIN: A RANDOMISED CONTROLLED TRIAL.

Dr Afusat Olabinjo0 sites176 target enrollmentJuly 21, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Helminthiasis
Sponsor
Dr Afusat Olabinjo
Enrollment
176
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 21, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Dr Afusat Olabinjo

Eligibility Criteria

Inclusion Criteria

  • All consenting pregnant women with singleton foetus presenting between 14 and 26 weeks.

Exclusion Criteria

  • Non consenting pregnant women.
  • Patients with known hypersensitivity to benzimidazole.
  • Baseline haemoglobin concentration less than 7g/dl.
  • Patients with multiple gestations.
  • Patients with sickle cell disease
  • Patients with chronic kidney disease.
  • Retroviral disease patients.
  • Patients that may require blood transfusion during the course of pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials